CHELA-FER® 15mg — Support Oxygen Transport & Red Blood Cell Formation
This clinical-grade iron supplement delivers elemental iron as ferrous bisglycinate chelate, a highly bioavailable form designed to maximise absorption and minimise gastrointestinal discomfort. By binding iron to organic amino acids, the molecule bypasses typical competitive absorption pathways in the digestive tract. Folic acid is co-formulated to synergistically assist in red blood cell development and protein metabolism. Regular administration helps replenish depleted iron stores, actively supporting systemic oxygen transport and reducing chronic fatigue.
Developed by Ascendis Health, CHELA-FER®® offers a highly effective pathway to rebuild depleted nutrient stores, restoring energy and vitality through advanced cellular support.
Recommended Usage
Adults and children 14 years and older: Take one tablet once daily after meals, or as directed by your healthcare practitioner.
Composition
| Serving size : 1 tablet | Amount per serving |
| Iron (elemental) from Ferrochel™ ferrous bisglycinate chelate 75,0 mg | 15mg |
| Folic acid | 250mcg |
Other Ingredients
Colloidal silicon dioxide, croscarmellose sodium, dicalcium phosphate dihydrate, hydroxypropyl cellulose, magnesium stearate, magnesium silicate hydroxide, microcrystalline cellulose, polyvinyl alcoholpolyethylene glycol copolymer, ponceau 4R lake MD, quinoline yellow aluminium lake and titanium dioxide
Does Not Contain
Sugar
Suitable for vegans and vegetarians
Storage
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
Product Form
Tablet
Warnings/Contraindication
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
Do not administer CHELA-FER® concomitantly with parenteral iron.
CHELA-FER® should not be given to patients with anaemias not produced by iron deficiency.
Recommended dosage(s) should not be exceeded unless on the advice of a healthcare practitioner.
Patients with the rare hereditary condition of sorbitol intolerance should not take CHELA-FER®.
Please review package insert (if available) for further information.



